I doubt that GNBT, with 50 millions, would have brought a vaccine in the market… They have agreements for free US and Chinese trials. After one year, all we get is serious problems, likely not related to lack of funding.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links